What is a rare cancer?
In the United States, a disease is considered rare if it affects fewer than 200,000 people. Rare cancers can be difficult to study because fewer people are diagnosed with them. With smaller patient populations, researchers may have less information to understand how a cancer develops, which treatments work best, and why some patients respond differently than others.
By sharing health information and experiences, people with rare cancers can help researchers learn more about these rare diseases and support the development of new treatments.
How is rare cancer research different?
For people living with rare diseases, treatment options can be limited or may not exist at all. One of the reasons rare cancers can be difficult to treat is that researchers don’t have much information about how a disease develops, grows, or responds to treatment. This means developing new treatments can also be challenging. Drugs developed to treat rare diseases are known as orphan drugs.
What is patient data?
Patient data is medical information about a person. Typically, this information is collected during diagnosis and treatment. However, medical history prior to diagnosis can also be important patient data.
Examples of patient data include:
Age
Diagnosis and disease subtype
Genetic mutations or biomarkers
Treatments history
How well a treatment worked
Side effects
Lab and test results
Medical history
Quality of life
Symptoms
For rare cancers, this information can be especially valuable because there are fewer patients for researchers to learn from.
How can patient data be helpful?
Patient data helps researchers better understand rare cancers. When information from many patients is studied together, researchers may be better able to identify patterns that might not be immediately apparent.
For example, patient data can help researchers learn about treatment response and resistance. It may also help identify common side effects, possible risk factors, or characteristics of patients who are more likely to benefit from certain treatments.
This information can also help researchers design clinical trials and develop new treatment options. For rare cancers, where clinical trials may have difficulty enrolling enough participants, information shared by patients can be particularly important.
Get involved
There are many ways to get involved with patient research. Sharing your experience can help researchers better understand rare cancers, expand treatment options, and ultimately lead to cures.
When you create a HealthTree account, you can upload your medical information and complete simple surveys that could help change the lives of others living with blood cancer.
Sources:
